Evidence map›Paper›PMID 32193685›Full record

ArticleHuman genetics2020

Delineation of phenotypes and genotypes related to cohesin structural protein RAD21.

Lianne C Krab, Iñigo Marcos-Alcalde, Melissa Assaf, Meena Balasubramanian, Janne Bayer Andersen, Anne-Marie Bisgaard, David R Fitzpatrick, Sanna Gudmundsson, Sylvia A Huisman, Tugba Kalayci and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Phenotypic Spectrum in Three Romanian Patients with 8q23-q24 Deletions.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. STAG2: Computational Analysis of Missense Variants Involved in Disease.International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Recurrent Germline Variant inInternational journal of molecular sciences · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 8 countries.

Lianne C KrabDepartment of Pediatrics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. lkrab@cordaan.nl.ORCID http://orcid.org/0000-0002-2480-2011
Iñigo Marcos-AlcaldeMolecular Modelling Group, Centro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), Madrid, Spain.ORCID http://orcid.org/0000-0002-0674-6423
Melissa AssafBanner Childrens Specialists Neurology Clinic, Glendale, AZ, USA.
Meena BalasubramanianClinical Genetics Service, Sheffield Children's Hospital, Academic Unit for Child Health, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-1488-3695
Janne Bayer AndersenDepartment of Clinical Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Gl. Landevej 7, 2600, Glostrup, Denmark.
Anne-Marie BisgaardDepartment of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.ORCID http://orcid.org/0000-0003-3592-9437
David R FitzpatrickMRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK.
Sanna GudmundssonDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-2332-074X
Sylvia A HuismanDepartment of Pediatrics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7666-1337
Tugba KalayciDivision of Medical Genetics, Department of Internal Medicine, Istanbul University, Istanbul, Turkey.
Saskia M MaasDepartment of Pediatrics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
Francisco MartinezUnidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0002-0589-2584
Shane McKeeNorthern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, UK.ORCID http://orcid.org/0000-0002-1772-0106
Leonie A MenkeDepartment of Pediatrics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8312-7730
Paul A MulderAutism Team Northern-Netherlands, Jonx Department of Youth Mental Health and Autism, Lentis Psychiatric Institute, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-9489-4022
Oliver D MurchInstitute of Medical Genetics, University Hospital of Wales, Cardiff, UK.
Michael ParkerClinical Genetic Service, Northern General Hospital, Sheffield, UK.
Juan PieUnit of Clinical Genetics Unit, Service of Pediatrics, University Hospital "Lozano Blesa", University of Zaragoza School of Medicine, Saragossa, Spain.
Feliciano J RamosUnit of Clinical Genetics Unit and Functional Genomics, Department of Pharmacology and Physiology, University of Zaragoza School of Medicine, Saragossa, Spain.ORCID http://orcid.org/0000-0002-5732-2209
Claudine RieublandDepartment of Pediatrics, Division of Human Genetics, Inselspital, University of Bern, Bern, Switzerland.
Jill A Rosenfeld MokryDepartment of Molecular and Human Genetics, Baylor College of Medicine, Baylor Genetics Laboratories, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5664-7987
Emanuela ScaranoRare Disease Unit, Department of Pediatrics, St. Orsola Hospital, Bologna, Italy.
Marwan ShinawiDepartment of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-1329-4100
Paulino Gómez-PuertasMolecular Modelling Group, Centro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), Madrid, Spain.ORCID http://orcid.org/0000-0003-3131-729X
Zeynep TümerDepartment of Clinical Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Gl. Landevej 7, 2600, Glostrup, Denmark. Zeynep.tumer@regionh.dk.ORCID http://orcid.org/0000-0002-4777-5802
Raoul C HennekamDepartment of Pediatrics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. R.c.hennekam@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-6745-1522
Amsterdam University Medical Centers · NLUniversidad de Zaragoza · ESAmsterdam Neuroscience · NLBaylor College of Medicine · USCentro de Biología Molecular Severo Ochoa · ESCopenhagen University Hospital · DKDermatology Specialists · USGlostrup Hospital · DKHospital Universitari i Politècnic La Fe · ESInstitute of Genetics and Cancer · GBIstanbul University · TRLentis · NLNorthern General Hospital · GBSanquin · NLSheffield Children's Hospital · GBUniversidad Francisco de Vitoria · ESUniversity Hospital of Wales · GBUniversity of Bern · CHUniversity of Copenhagen · DKUniversity of Ulster · GB

Funding

JPIAMR-VRI ConnectMedical Research Council MC_UU_00007/3Spanish Ministery of Science RTI2018-094434-B-I00Spanish Ministry of Science RTC-2017-6494-1
6 · The paper itself

Abstract

RAD21 encodes a key component of the cohesin complex, and variants in RAD21 have been associated with Cornelia de Lange Syndrome (CdLS). Limited information on phenotypes attributable to RAD21 variants and genotype-phenotype relationships is currently published. We gathered a series of 49 individuals from 33 families with RAD21 alterations [24 different intragenic sequence variants (2 recurrent), 7 unique microdeletions], including 24 hitherto unpublished cases. We evaluated consequences of 12 intragenic variants by protein modelling and molecular dynamic studies. Full clinical information was available for 29 individuals. Their phenotype is an attenuated CdLS phenotype compared to that caused by variants in NIPBL or SMC1A for facial morphology, limb anomalies, and especially for cognition and behavior. In the 20 individuals with limited clinical information, additional phenotypes include Mungan syndrome (in patients with biallelic variants) and holoprosencephaly, with or without CdLS characteristics. We describe several additional cases with phenotypes including sclerocornea, in which involvement of the RAD21 variant is uncertain. Variants were frequently familial, and genotype-phenotype analyses demonstrated striking interfamilial and intrafamilial variability. Careful phenotyping is essential in interpreting consequences of RAD21 variants, and protein modeling and dynamics can be helpful in determining pathogenicity. The current study should be helpful when counseling families with a RAD21 variation.

Indexed as

Chromosome DeletionMutationAdolescentAdultCell Cycle ProteinsChildChild, PreschoolDe Lange SyndromeDNA-Binding ProteinsFemaleGenetic Association StudiesGenotypeHumansInfantInfant, NewbornMaleCell Cycle ProteinsDNA-Binding ProteinsRAD21 protein, human

Identifiers

PMID32193685
PMCPMC7170815
OpenAlexW3012339221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.